Skip to main content
. 2024 Feb 24;130(8):1269–1278. doi: 10.1038/s41416-024-02604-y

Fig. 4. Forest plot—PFS in KRAS wild-type subgroup.

Fig. 4

Forest plot of progression-free survival for KRAS wild-type subgroup of patients treated with EGFR mAb + chemo/BSC versus chemo/BSC alone. EGFR epidermal growth factor receptor.